Clinical Trial Update: Apixaban in Hemodialysis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update reports the completion of a study evaluating apixaban in patients on hemodialysis for end-stage renal disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Eliquis (apixaban)

Snippet

Sponsor: Jewish General Hospital | Conditions: End-stage Renal Disease | Phase 4 | Status: COMPLETED